Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Policy Change Made Reality in 2021

Thomas R. Collins  |  November 18, 2021

ACR CONVERGENCE 2021—Advocacy leaders for the ACR outlined a host of victories and challenges in a session at ACR Convergence 2021, while underscoring the importance of member involvement to help drive policy changes that will help rheumatologists and their patients.

Blair Solow

Dr. Blair Solow

Elizabeth (Blair) Solow, MD, chair of the ACR Government Affairs Committee, outlined several big wins that resulted from the College’s advocacy efforts during the past year. Those achievements include maintenance of recent gains in evaluation and management coding in the CY2022 Medicare Physician Fee Schedule Final Rule, as well as extended flexibilities for telehealth and acceptance of the rheumatology-specific Merit-Based Incentive Payment System (MIPS) Value Pathway, which will simplify rheumatologists’ participation in MIPS.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In addition, the Pediatric Subspecialty Loan Repayment Program was reauthorized this year, with $25 million proposed to fund the program for the first time. “If we can get this through appropriations, this will be a huge win for our pediatric colleagues,” Dr. Solow said.

Advocacy Hill Days in May and September—attended by nearly 200 ACR members, rheumatology professionals and patients in total—were particularly effective, Dr. Solow said. Groups spoke with members of Congress and their staff about step therapy, prior authorization policies, and drug pricing issues and their effects on practices and patient access to care. Since those meetings took place, ACR staff and volunteer leaders have noted increased awareness and co-signers on related bills. 

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Current efforts are directed toward blocking the significant cuts to Medicare reimbursement scheduled to take effect at the beginning of 2022. Lennie McDaniel, JD, director of congressional regulatory affairs for the ACR, said the College is working to avoid these cuts, which would amount to nearly a 10% reduction in Medicare reimbursement rates for providers, including rheumatologists.

Dr. Solow encouraged all providers to send letters to their representatives to support a legislative fix for these cuts, saying, “This is incredibly important to move the needle and push these policies forward.”

Looking Ahead

With the focus of Congress over the past several months on big spending bills that are the cornerstone of President Biden’s agenda, there has not been much opportunity to focus on other, more specific legislation, Ms. McDaniel noted.

“Our hope is once we turn over the new year, those things will have been resolved and we can go back to focusing on some of the more one-off, specific topics that really drill down and deal with issues specific to day-to-day practice and patient care,” she said.

Page: 1 2 3 | Single Page
Share: 

Filed under:ACR ConvergenceLegislation & AdvocacyMeeting Reports Tagged with:ACR advocacyACR Convergence 2021

Related Articles

    Telehealth Brings Opportunities to Enhance Patient Care

    December 8, 2022

    During an ACR webinar in August, presenters discussed multiple aspects of telehealth in rheumatology, especially related to rheumatology fellowship training. They agreed that although telehealth represents one potential avenue to improve patient access to treatment for rheumatic disease, we must keep identifying the best ways to employ telehealth to enhance care. Impact of Pandemic Telemedicine…

    Telerheumatology: What’s Next?

    December 17, 2020

    In an ACR Convergence session, two rheumatologists discussed how COVID-19 changed the use of telemedicine, how payers reacted and which changes are likely permanent and which are likely to be temporary.

    What’s Next for Telehealth after the COVID-19 Public Health Emergency?

    June 10, 2023

    Do you remember where you were when the COVID-19 Public Health Emergency (PHE) was declared on Jan. 31, 2020? While it may seem like yesterday, you would be forgiven for not recalling your exact location over three years ago during what felt like an incredible whirlwind for the healthcare industry. One possible location you may…

    Providers & Patients Talk to Legislators about Telehealth, Workforce Shortage

    September 18, 2020

    On Sept. 15, rheumatology advocates met virtually with members of Congress to share personal accounts of how telehealth is making a difference during the COVID-19 pandemic and what will help stem a workforce shortage.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences